Loratadine-D Extended-Release Tablets recall
Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15
Why was Loratadine-D Extended-Release Tablets recalled?
Failed Moisture Limits
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: AC14635, Exp. Date 12/2022
- Product
- Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC
- Quantity
- 22,752 blister packs
- Distribution
- Nationwide within the United States
- Recall date
- November 3, 2021
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)